Prostazen
NDC 80353-702, Enlarged Prostate, Prostatic Utricle Function, and Prostatitis Recovery, capsule, from HCBIOPHARM LLC.
- Product NDC
- 80353-702
- Status
- Listed
- Labeler
- HCBIOPHARM LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80353-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SAW PALMETTO1 [hp_X]/1
- RUBIA CORDIFOLIA ROOT1 [hp_X]/1
- REYNOUTRIA JAPONICA ROOT1 [hp_X]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80353-702-01 | 80353070201 | 1 BOTTLE in 1 BOX (80353-702-01) / 1 CAPSULE in 1 BOTTLE (80353-702-02) / 60 CAPSULE in 1 CAPSULE (80353-702-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 80353-702 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80353-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80353-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.